Clinical Trials Browser

Recurrence × lenvatinib × Gastrointestinal × Clear all

NCT07077798 2025-07-22

Adjuvant Sintilimab Plus Lenvatinib for HCC Characterized With VETC Following Liver Resection

Phase NA Not yet recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Recurrence

NCT06420440 2025-05-01

Neoadjuvant Therapy in Patients With Resectable HCC Screened by a Multimodal Deep Learning Model

Phase 2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Recurrence

NCT05910970 2024-01-23

PREVENT-2

Phase 3 Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Recurrence